Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients

[1]  N. Siafakas,et al.  Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. , 2012, Chest.

[2]  L. Dupont,et al.  Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century , 2010, Postgraduate Medical Journal.

[3]  S. Bourke,et al.  Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa , 2010, Thorax.

[4]  G. Filippatos,et al.  Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .

[5]  C. Pignata,et al.  Assessment of Chest High-Field Magnetic Resonance Imaging in Children and Young Adults With Noncystic Fibrosis Chronic Lung Disease: Comparison to High-Resolution Computed Tomography and Correlation With Pulmonary Function , 2009, Investigative radiology.

[6]  A. Hill,et al.  Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis , 2009, European Respiratory Journal.

[7]  D. Hansell,et al.  Mortality in bronchiectasis: a long-term study assessing the factors influencing survival , 2009, European Respiratory Journal.

[8]  A. Hill,et al.  Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis , 2009, European Respiratory Journal.

[9]  P. Hutchinson,et al.  Bactericidal activity of neutrophils with reduced oxidative burst from adults with bronchiectasis , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[10]  G. Redding,et al.  Physical and transport properties of sputum from children with idiopathic bronchiectasis. , 2008, Chest.

[11]  D. Bilton.  Update on non-cystic fibrosis bronchiectasis , 2008, Current opinion in pulmonary medicine.

[12]  A. Alzeer,et al.  Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis. , 2008, Chest.

[13]  J. Soriano,et al.  Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. , 2007, Chest.

[14]  P. King,et al.  Microbiologic follow-up study in adult bronchiectasis. , 2007, Respiratory medicine.

[15]  R. Wilson,et al.  Aetiology in adult patients with bronchiectasis. , 2007, Respiratory medicine.

[16]  Ariel Roguin,et al.  Rene Theophile Hyacinthe Laënnec (1781-1826): the man behind the stethoscope. , 2006, Clinical medicine & research.

[17]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[18]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[19]  J. Hankinson,et al.  General considerations for lung function testing , 2005, European Respiratory Journal.

[20]  C. Byrnes,et al.  New Zealand national incidence of bronchiectasis “too high” for a developed country , 2005, Archives of Disease in Childhood.

[21]  P. Molina,et al.  High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. , 2004, The Journal of pediatrics.

[22]  B. Morrissey,et al.  Bronchiectasis: sex and gender considerations. , 2004, Clinics in chest medicine.

[23]  G. Tipoe,et al.  Bronchiectasis: not an orphan disease in the East. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  A. Fall,et al.  The need to redefine non-cystic fibrosis bronchiectasis in childhood , 2004, Thorax.

[25]  A. Chang,et al.  Bronchiectasis in Indigenous children in remote Australian communities , 2002, The Medical journal of Australia.

[26]  R. Rodríguez-Roisín,et al.  Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors , 2002, Thorax.

[27]  U. Prakash.  An investigation into causative factors in patients with bronchiectasis , 2001 .

[28]  M. Keogan,et al.  An investigation into causative factors in patients with bronchiectasis. , 2000, American journal of respiratory and critical care medicine.

[29]  G. Redding,et al.  Bronchiectasis in Alaska Native children: causes and clinical courses. , 2000, Pediatric pulmonology.

[30]  P. Ho,et al.  A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis. , 1999, The European respiratory journal.

[31]  P. Jones,et al.  Systemic markers of inflammation in stable bronchiectasis. , 1998, The European respiratory journal.

[32]  S. Kivelä,et al.  Evaluation of the incidence and age distribution of bronchiectasis from the Finnish hospital discharge register. , 1998, Central European journal of public health.

[33]  A. O'donnell,et al.  Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. , 1998, Chest.

[34]  P. Jones,et al.  Validation of the St. George's Respiratory Questionnaire in bronchiectasis. , 1997, American journal of respiratory and critical care medicine.

[35]  A. Friedman,et al.  High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation. , 1997, AJR. American journal of roentgenology.

[36]  D M Hansell,et al.  CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. , 1995, AJR. American journal of roentgenology.

[37]  J. C. Hoyle,et al.  Observations on DRY BRONCHIECTASIS , 1933, British medical journal.